<DOC>
	<DOC>NCT01596010</DOC>
	<brief_summary>This trial is conducted in Europe. The aim of this trial is to investigate whether a reformulated estradiol/norethisterone acetate (NETA) formulation is bioequivalent to that of KliogestÂ® (estradiol/norethisterone acetate (NETA) in healthy women.</brief_summary>
	<brief_title>Investigation of 2 Different Oral Formulations of Estradiol and Norethisterone in Healthy Women</brief_title>
	<detailed_description />
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<criteria>Postmenopausal defined as at least 12 months spontaneous amenorrhoea, with serum FSH (follicle stimulating hormone) levels at least 40 IU/L and estradiol maximum 25 pg/mL. If the date of spontaneous amenorrhoea can not be identified because of previous hormone replacement therapy, serum FSH at least 40 IU/L and estradiol maximum 25 pg/mL Nonsmoking Body Mass Index (BMI) maximum 35.0 kg/m^2 Able to understand, read and speak German fluently Good state of health evidenced by medical history, physical examination including gynecological examination, and results from laboratory examination Willing to abstain from intake of caffeine containing food and beverages within 48 hours before drug administration Known or suspected allergy to trial products or related products Previous use of oral, transdermal, nasal spray, vaginal preparations and implants within 8 weeks prior to the planned first drug administration Known, suspected or history of breast cancer Known or suspected estrogen dependent neoplasia e.g. endometrial cancer Abnormal genital bleeding of unknown aetiology Known insulin dependent as well as noninsulin dependent diabetes mellitus Positive test for HIV (human immunodeficiency virus) and/or hepatitis B and C Systolic blood pressure (BP) above or equal to 160 mm Hg and/or diastolic BP above or equal to 100 mm Hg, currently treated or untreated</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>